Dublin, April 10, 2023 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Diagnosis Tests: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Rheumatoid Arthritis Diagnosis Tests estimated at US$629.9 Million in the year 2022, is projected to reach a revised size of US$944.9 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2022-2030.
Serology Tests, one of the segments analyzed in the report, is projected to record 5.5% CAGR and reach US$667.3 Million by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Monitoring Ra Treatment Efficiency Tests segment is readjusted to a revised 4.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $129.4 Million, While China is Forecast to Grow at 6.5% CAGR
The Rheumatoid Arthritis Diagnosis Tests market in the U.S. is estimated at US$129.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$146.3 Million by the year 2030 trailing a CAGR of 6.5% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 4.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
Select Competitors (Total 65 Featured) -
- Abbott Diagnostics
- Augurex Life Sciences Corp.
- Beckman Coulter, Inc.
- Bio Rad Laboratories Inc.
- Exagen Inc.
- F. Hoffmann-La Roche Ltd.
- Genway Biotech, Inc.
- Microdrop LLC (imaware)
- Qiagen NV
- Siemens Healthcare GmbH
- Svar Life Science AB
- Thermo Fisher Scientific Inc.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 393 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $629.9 Million |
| Forecasted Market Value (USD) by 2030 | $944.9 Million |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Rheumatoid Arthritis Diagnosis Tests - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- A Prelude to Rheumatoid Arthritis
- Causes and Risk Factors
- Symptoms
- Rheumatoid Arthritis Diagnostic Tests
- Serological Tests
- Monitoring RA Treatment Efficiency Tests
- Kidney Function Tests
- Impact of Covid-19 and a Looming Global Recession
- Impact of COVID-19 on Rheumatoid Arthritis Diagnostic Tests
- Global Market Outlook and Prospects
- Global Rheumatoid Arthritis Diagnostic Tests Market Set to Witness Significant Growth
- Select RA Diagnostic Tests by Player
- The US and Europe Dominate the Global Market, Developing Countries to Witness Fastest Growth
- Competition
- Recent Market Activity
- Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Incidence of Rheumatoid Arthritis Propels the Demand for Rheumatoid Arthritis Diagnosis
- Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
- Growing Aging Population to Drive the Demand for RA Diagnostic Tests
- Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Increasing Use of Rapid Diagnosis Tests Platform
- Select List of RA Biomarkers used in Clinical Practice
- Investigational Biomarkers to Diagnose and Monitor RA
- New Biomarker Tests to Drive the Market Growth
- More Specific Biomarker Tests
- Growing Demand for Multiple Tests
- Repercussions of Sub Optimal Accuracy in RA Testing Drive the Need for Multiple Tests
- Recent Advancements in Treatment Methods to Boost Market Growth
- Uptrend in Healthcare Expenditure Drives Opportunities
- World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
- Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
- Increasing Obesity Levels Underpins Market Growth
- Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
- Technological Advancements Widen the Capabilities of RA Arthritis Tests
- A Few of the Recent Launches and Advancements
- Rapid RA Diagnostic Tests for Obtaining Results in Minutes
- imawareT Introduces At-Home Rheumatoid Arthritis Screening Test
- Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test
- Scipher Medicine Ties Up with Ambry Genetics to Bring Precision Medicine Test for Rheumatoid Arthritis to Market
- A New Blood Test Could to Predict Rheumatoid Arthritis
- A New Blood Test Could to Predict Rheumatoid Arthritis
- IPM Launches Innovative Program for Rheumatoid Arthritis
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/fy6ez5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
